Global Gabapentin Enacarbil Market Insights, Forecast to 2028

  • Report ID:239372
  • Industry Name: Pharma & Healthcare
  • Publishing Date: Jun-22
  • No. of Pages: 117
                              
Gabapentin Enacarbil market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Gabapentin Enacarbil market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Capsule Tablet Segment by Application Post-Herpetic Neuralgia (PHN) Restless Legs Syndrome (RLS) Others By Company Arbor Pharma Astellas GlaxoSmithKline Glenmark Pharma Pfizer Depomed Teva Mylan Novartis Apotex Sun Pharmaceutical Aurobindo Pharma Intas Amneal Marksans Pharma Alkem Jiangsu Enhua Jiangsu Hengrui Sailike Pharma By Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE
                        
1 Study Coverage 1.1 Gabapentin Enacarbil Product Introduction 1.2 Market by Type 1.2.1 Global Gabapentin Enacarbil Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Capsule 1.2.3 Tablet 1.3 Market by Application 1.3.1 Global Gabapentin Enacarbil Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Post-Herpetic Neuralgia (PHN) 1.3.3 Restless Legs Syndrome (RLS) 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Gabapentin Enacarbil Sales Estimates and Forecasts 2017-2028 2.2 Global Gabapentin Enacarbil Revenue Estimates and Forecasts 2017-2028 2.3 Global Gabapentin Enacarbil Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Gabapentin Enacarbil Sales by Region 2.4.1 Global Gabapentin Enacarbil Sales by Region (2017-2022) 2.4.2 Global Sales Gabapentin Enacarbil by Region (2023-2028) 2.5 Global Gabapentin Enacarbil Revenue by Region 2.5.1 Global Gabapentin Enacarbil Revenue by Region (2017-2022) 2.5.2 Global Gabapentin Enacarbil Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Gabapentin Enacarbil Sales by Manufacturers 3.1.1 Global Top Gabapentin Enacarbil Manufacturers by Sales (2017-2022) 3.1.2 Global Gabapentin Enacarbil Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Gabapentin Enacarbil in 2021 3.2 Global Gabapentin Enacarbil Revenue by Manufacturers 3.2.1 Global Gabapentin Enacarbil Revenue by Manufacturers (2017-2022) 3.2.2 Global Gabapentin Enacarbil Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Gabapentin Enacarbil Revenue in 2021 3.3 Global Gabapentin Enacarbil Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Gabapentin Enacarbil Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Gabapentin Enacarbil Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Gabapentin Enacarbil Sales by Type 4.1.1 Global Gabapentin Enacarbil Historical Sales by Type (2017-2022) 4.1.2 Global Gabapentin Enacarbil Forecasted Sales by Type (2023-2028) 4.1.3 Global Gabapentin Enacarbil Sales Market Share by Type (2017-2028) 4.2 Global Gabapentin Enacarbil Revenue by Type 4.2.1 Global Gabapentin Enacarbil Historical Revenue by Type (2017-2022) 4.2.2 Global Gabapentin Enacarbil Forecasted Revenue by Type (2023-2028) 4.2.3 Global Gabapentin Enacarbil Revenue Market Share by Type (2017-2028) 4.3 Global Gabapentin Enacarbil Price by Type 4.3.1 Global Gabapentin Enacarbil Price by Type (2017-2022) 4.3.2 Global Gabapentin Enacarbil Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Gabapentin Enacarbil Sales by Application 5.1.1 Global Gabapentin Enacarbil Historical Sales by Application (2017-2022) 5.1.2 Global Gabapentin Enacarbil Forecasted Sales by Application (2023-2028) 5.1.3 Global Gabapentin Enacarbil Sales Market Share by Application (2017-2028) 5.2 Global Gabapentin Enacarbil Revenue by Application 5.2.1 Global Gabapentin Enacarbil Historical Revenue by Application (2017-2022) 5.2.2 Global Gabapentin Enacarbil Forecasted Revenue by Application (2023-2028) 5.2.3 Global Gabapentin Enacarbil Revenue Market Share by Application (2017-2028) 5.3 Global Gabapentin Enacarbil Price by Application 5.3.1 Global Gabapentin Enacarbil Price by Application (2017-2022) 5.3.2 Global Gabapentin Enacarbil Price Forecast by Application (2023-2028) 6 North America 6.1 North America Gabapentin Enacarbil Market Size by Type 6.1.1 North America Gabapentin Enacarbil Sales by Type (2017-2028) 6.1.2 North America Gabapentin Enacarbil Revenue by Type (2017-2028) 6.2 North America Gabapentin Enacarbil Market Size by Application 6.2.1 North America Gabapentin Enacarbil Sales by Application (2017-2028) 6.2.2 North America Gabapentin Enacarbil Revenue by Application (2017-2028) 6.3 North America Gabapentin Enacarbil Market Size by Country 6.3.1 North America Gabapentin Enacarbil Sales by Country (2017-2028) 6.3.2 North America Gabapentin Enacarbil Revenue by Country (2017-2028) 6.3.3 United States 6.3.4 Canada 7 Europe 7.1 Europe Gabapentin Enacarbil Market Size by Type 7.1.1 Europe Gabapentin Enacarbil Sales by Type (2017-2028) 7.1.2 Europe Gabapentin Enacarbil Revenue by Type (2017-2028) 7.2 Europe Gabapentin Enacarbil Market Size by Application 7.2.1 Europe Gabapentin Enacarbil Sales by Application (2017-2028) 7.2.2 Europe Gabapentin Enacarbil Revenue by Application (2017-2028) 7.3 Europe Gabapentin Enacarbil Market Size by Country 7.3.1 Europe Gabapentin Enacarbil Sales by Country (2017-2028) 7.3.2 Europe Gabapentin Enacarbil Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Gabapentin Enacarbil Market Size by Type 8.1.1 Asia Pacific Gabapentin Enacarbil Sales by Type (2017-2028) 8.1.2 Asia Pacific Gabapentin Enacarbil Revenue by Type (2017-2028) 8.2 Asia Pacific Gabapentin Enacarbil Market Size by Application 8.2.1 Asia Pacific Gabapentin Enacarbil Sales by Application (2017-2028) 8.2.2 Asia Pacific Gabapentin Enacarbil Revenue by Application (2017-2028) 8.3 Asia Pacific Gabapentin Enacarbil Market Size by Region 8.3.1 Asia Pacific Gabapentin Enacarbil Sales by Region (2017-2028) 8.3.2 Asia Pacific Gabapentin Enacarbil Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 China Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 9 Latin America 9.1 Latin America Gabapentin Enacarbil Market Size by Type 9.1.1 Latin America Gabapentin Enacarbil Sales by Type (2017-2028) 9.1.2 Latin America Gabapentin Enacarbil Revenue by Type (2017-2028) 9.2 Latin America Gabapentin Enacarbil Market Size by Application 9.2.1 Latin America Gabapentin Enacarbil Sales by Application (2017-2028) 9.2.2 Latin America Gabapentin Enacarbil Revenue by Application (2017-2028) 9.3 Latin America Gabapentin Enacarbil Market Size by Country 9.3.1 Latin America Gabapentin Enacarbil Sales by Country (2017-2028) 9.3.2 Latin America Gabapentin Enacarbil Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Gabapentin Enacarbil Market Size by Type 10.1.1 Middle East and Africa Gabapentin Enacarbil Sales by Type (2017-2028) 10.1.2 Middle East and Africa Gabapentin Enacarbil Revenue by Type (2017-2028) 10.2 Middle East and Africa Gabapentin Enacarbil Market Size by Application 10.2.1 Middle East and Africa Gabapentin Enacarbil Sales by Application (2017-2028) 10.2.2 Middle East and Africa Gabapentin Enacarbil Revenue by Application (2017-2028) 10.3 Middle East and Africa Gabapentin Enacarbil Market Size by Country 10.3.1 Middle East and Africa Gabapentin Enacarbil Sales by Country (2017-2028) 10.3.2 Middle East and Africa Gabapentin Enacarbil Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Arbor Pharma 11.1.1 Arbor Pharma Corporation Information 11.1.2 Arbor Pharma Overview 11.1.3 Arbor Pharma Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Arbor Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Arbor Pharma Recent Developments 11.2 Astellas 11.2.1 Astellas Corporation Information 11.2.2 Astellas Overview 11.2.3 Astellas Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Astellas Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Astellas Recent Developments 11.3 GlaxoSmithKline 11.3.1 GlaxoSmithKline Corporation Information 11.3.2 GlaxoSmithKline Overview 11.3.3 GlaxoSmithKline Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 GlaxoSmithKline Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 GlaxoSmithKline Recent Developments 11.4 Glenmark Pharma 11.4.1 Glenmark Pharma Corporation Information 11.4.2 Glenmark Pharma Overview 11.4.3 Glenmark Pharma Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Glenmark Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Glenmark Pharma Recent Developments 11.5 Pfizer 11.5.1 Pfizer Corporation Information 11.5.2 Pfizer Overview 11.5.3 Pfizer Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Pfizer Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Pfizer Recent Developments 11.6 Depomed 11.6.1 Depomed Corporation Information 11.6.2 Depomed Overview 11.6.3 Depomed Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Depomed Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Depomed Recent Developments 11.7 Teva 11.7.1 Teva Corporation Information 11.7.2 Teva Overview 11.7.3 Teva Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Teva Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Teva Recent Developments 11.8 Mylan 11.8.1 Mylan Corporation Information 11.8.2 Mylan Overview 11.8.3 Mylan Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Mylan Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Mylan Recent Developments 11.9 Novartis 11.9.1 Novartis Corporation Information 11.9.2 Novartis Overview 11.9.3 Novartis Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Novartis Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Novartis Recent Developments 11.10 Apotex 11.10.1 Apotex Corporation Information 11.10.2 Apotex Overview 11.10.3 Apotex Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 Apotex Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Apotex Recent Developments 11.11 Sun Pharmaceutical 11.11.1 Sun Pharmaceutical Corporation Information 11.11.2 Sun Pharmaceutical Overview 11.11.3 Sun Pharmaceutical Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022) 11.11.4 Sun Pharmaceutical Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications 11.11.5 Sun Pharmaceutical Recent Developments 11.12 Aurobindo Pharma 11.12.1 Aurobindo Pharma Corporation Information 11.12.2 Aurobindo Pharma Overview 11.12.3 Aurobindo Pharma Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022) 11.12.4 Aurobindo Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications 11.12.5 Aurobindo Pharma Recent Developments 11.13 Intas 11.13.1 Intas Corporation Information 11.13.2 Intas Overview 11.13.3 Intas Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022) 11.13.4 Intas Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications 11.13.5 Intas Recent Developments 11.14 Amneal 11.14.1 Amneal Corporation Information 11.14.2 Amneal Overview 11.14.3 Amneal Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022) 11.14.4 Amneal Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications 11.14.5 Amneal Recent Developments 11.15 Marksans Pharma 11.15.1 Marksans Pharma Corporation Information 11.15.2 Marksans Pharma Overview 11.15.3 Marksans Pharma Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022) 11.15.4 Marksans Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications 11.15.5 Marksans Pharma Recent Developments 11.16 Alkem 11.16.1 Alkem Corporation Information 11.16.2 Alkem Overview 11.16.3 Alkem Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022) 11.16.4 Alkem Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications 11.16.5 Alkem Recent Developments 11.17 Jiangsu Enhua 11.17.1 Jiangsu Enhua Corporation Information 11.17.2 Jiangsu Enhua Overview 11.17.3 Jiangsu Enhua Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022) 11.17.4 Jiangsu Enhua Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications 11.17.5 Jiangsu Enhua Recent Developments 11.18 Jiangsu Hengrui 11.18.1 Jiangsu Hengrui Corporation Information 11.18.2 Jiangsu Hengrui Overview 11.18.3 Jiangsu Hengrui Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022) 11.18.4 Jiangsu Hengrui Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications 11.18.5 Jiangsu Hengrui Recent Developments 11.19 Sailike Pharma 11.19.1 Sailike Pharma Corporation Information 11.19.2 Sailike Pharma Overview 11.19.3 Sailike Pharma Gabapentin Enacarbil Sales, Price, Revenue and Gross Margin (2017-2022) 11.19.4 Sailike Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications 11.19.5 Sailike Pharma Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Gabapentin Enacarbil Industry Chain Analysis 12.2 Gabapentin Enacarbil Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Gabapentin Enacarbil Production Mode & Process 12.4 Gabapentin Enacarbil Sales and Marketing 12.4.1 Gabapentin Enacarbil Sales Channels 12.4.2 Gabapentin Enacarbil Distributors 12.5 Gabapentin Enacarbil Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Gabapentin Enacarbil Industry Trends 13.2 Gabapentin Enacarbil Market Drivers 13.3 Gabapentin Enacarbil Market Challenges 13.4 Gabapentin Enacarbil Market Restraints 14 Key Findings in The Global Gabapentin Enacarbil Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
                
List of Tables Table 1. Global Gabapentin Enacarbil Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Capsule Table 3. Major Manufacturers of Tablet Table 4. Global Gabapentin Enacarbil Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 5. Global Gabapentin Enacarbil Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 6. Global Gabapentin Enacarbil Sales by Region (2017-2022) & (K Units) Table 7. Global Gabapentin Enacarbil Sales Market Share by Region (2017-2022) Table 8. Global Gabapentin Enacarbil Sales by Region (2023-2028) & (K Units) Table 9. Global Gabapentin Enacarbil Sales Market Share by Region (2023-2028) Table 10. Global Gabapentin Enacarbil Revenue by Region (2017-2022) & (US$ Million) Table 11. Global Gabapentin Enacarbil Revenue Market Share by Region (2017-2022) Table 12. Global Gabapentin Enacarbil Revenue by Region (2023-2028) & (US$ Million) Table 13. Global Gabapentin Enacarbil Revenue Market Share by Region (2023-2028) Table 14. Global Gabapentin Enacarbil Sales by Manufacturers (2017-2022) & (K Units) Table 15. Global Gabapentin Enacarbil Sales Share by Manufacturers (2017-2022) Table 16. Global Gabapentin Enacarbil Revenue by Manufacturers (2017-2022) & (US$ Million) Table 17. Global Gabapentin Enacarbil Revenue Share by Manufacturers (2017-2022) Table 18. Gabapentin Enacarbil Price by Manufacturers (2017-2022) &(US$/Unit) Table 19. Global Gabapentin Enacarbil Manufacturers Market Concentration Ratio (CR5 and HHI) Table 20. Global Gabapentin Enacarbil by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gabapentin Enacarbil as of 2021) Table 21. Gabapentin Enacarbil Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Gabapentin Enacarbil Product Offered Table 23. Date of Manufacturers Enter into Gabapentin Enacarbil Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Gabapentin Enacarbil Sales by Type (2017-2022) & (K Units) Table 26. Global Gabapentin Enacarbil Sales by Type (2023-2028) & (K Units) Table 27. Global Gabapentin Enacarbil Sales Share by Type (2017-2022) Table 28. Global Gabapentin Enacarbil Sales Share by Type (2023-2028) Table 29. Global Gabapentin Enacarbil Revenue by Type (2017-2022) & (US$ Million) Table 30. Global Gabapentin Enacarbil Revenue by Type (2023-2028) & (US$ Million) Table 31. Global Gabapentin Enacarbil Revenue Share by Type (2017-2022) Table 32. Global Gabapentin Enacarbil Revenue Share by Type (2023-2028) Table 33. Gabapentin Enacarbil Price by Type (2017-2022) & (US$/Unit) Table 34. Global Gabapentin Enacarbil Price Forecast by Type (2023-2028) & (US$/Unit) Table 35. Global Gabapentin Enacarbil Sales by Application (2017-2022) & (K Units) Table 36. Global Gabapentin Enacarbil Sales by Application (2023-2028) & (K Units) Table 37. Global Gabapentin Enacarbil Sales Share by Application (2017-2022) Table 38. Global Gabapentin Enacarbil Sales Share by Application (2023-2028) Table 39. Global Gabapentin Enacarbil Revenue by Application (2017-2022) & (US$ Million) Table 40. Global Gabapentin Enacarbil Revenue by Application (2023-2028) & (US$ Million) Table 41. Global Gabapentin Enacarbil Revenue Share by Application (2017-2022) Table 42. Global Gabapentin Enacarbil Revenue Share by Application (2023-2028) Table 43. Gabapentin Enacarbil Price by Application (2017-2022) & (US$/Unit) Table 44. Global Gabapentin Enacarbil Price Forecast by Application (2023-2028) & (US$/Unit) Table 45. North America Gabapentin Enacarbil Sales by Type (2017-2022) & (K Units) Table 46. North America Gabapentin Enacarbil Sales by Type (2023-2028) & (K Units) Table 47. North America Gabapentin Enacarbil Revenue by Type (2017-2022) & (US$ Million) Table 48. North America Gabapentin Enacarbil Revenue by Type (2023-2028) & (US$ Million) Table 49. North America Gabapentin Enacarbil Sales by Application (2017-2022) & (K Units) Table 50. North America Gabapentin Enacarbil Sales by Application (2023-2028) & (K Units) Table 51. North America Gabapentin Enacarbil Revenue by Application (2017-2022) & (US$ Million) Table 52. North America Gabapentin Enacarbil Revenue by Application (2023-2028) & (US$ Million) Table 53. North America Gabapentin Enacarbil Sales by Country (2017-2022) & (K Units) Table 54. North America Gabapentin Enacarbil Sales by Country (2023-2028) & (K Units) Table 55. North America Gabapentin Enacarbil Revenue by Country (2017-2022) & (US$ Million) Table 56. North America Gabapentin Enacarbil Revenue by Country (2023-2028) & (US$ Million) Table 57. Europe Gabapentin Enacarbil Sales by Type (2017-2022) & (K Units) Table 58. Europe Gabapentin Enacarbil Sales by Type (2023-2028) & (K Units) Table 59. Europe Gabapentin Enacarbil Revenue by Type (2017-2022) & (US$ Million) Table 60. Europe Gabapentin Enacarbil Revenue by Type (2023-2028) & (US$ Million) Table 61. Europe Gabapentin Enacarbil Sales by Application (2017-2022) & (K Units) Table 62. Europe Gabapentin Enacarbil Sales by Application (2023-2028) & (K Units) Table 63. Europe Gabapentin Enacarbil Revenue by Application (2017-2022) & (US$ Million) Table 64. Europe Gabapentin Enacarbil Revenue by Application (2023-2028) & (US$ Million) Table 65. Europe Gabapentin Enacarbil Sales by Country (2017-2022) & (K Units) Table 66. Europe Gabapentin Enacarbil Sales by Country (2023-2028) & (K Units) Table 67. Europe Gabapentin Enacarbil Revenue by Country (2017-2022) & (US$ Million) Table 68. Europe Gabapentin Enacarbil Revenue by Country (2023-2028) & (US$ Million) Table 69. Asia Pacific Gabapentin Enacarbil Sales by Type (2017-2022) & (K Units) Table 70. Asia Pacific Gabapentin Enacarbil Sales by Type (2023-2028) & (K Units) Table 71. Asia Pacific Gabapentin Enacarbil Revenue by Type (2017-2022) & (US$ Million) Table 72. Asia Pacific Gabapentin Enacarbil Revenue by Type (2023-2028) & (US$ Million) Table 73. Asia Pacific Gabapentin Enacarbil Sales by Application (2017-2022) & (K Units) Table 74. Asia Pacific Gabapentin Enacarbil Sales by Application (2023-2028) & (K Units) Table 75. Asia Pacific Gabapentin Enacarbil Revenue by Application (2017-2022) & (US$ Million) Table 76. Asia Pacific Gabapentin Enacarbil Revenue by Application (2023-2028) & (US$ Million) Table 77. Asia Pacific Gabapentin Enacarbil Sales by Region (2017-2022) & (K Units) Table 78. Asia Pacific Gabapentin Enacarbil Sales by Region (2023-2028) & (K Units) Table 79. Asia Pacific Gabapentin Enacarbil Revenue by Region (2017-2022) & (US$ Million) Table 80. Asia Pacific Gabapentin Enacarbil Revenue by Region (2023-2028) & (US$ Million) Table 81. Latin America Gabapentin Enacarbil Sales by Type (2017-2022) & (K Units) Table 82. Latin America Gabapentin Enacarbil Sales by Type (2023-2028) & (K Units) Table 83. Latin America Gabapentin Enacarbil Revenue by Type (2017-2022) & (US$ Million) Table 84. Latin America Gabapentin Enacarbil Revenue by Type (2023-2028) & (US$ Million) Table 85. Latin America Gabapentin Enacarbil Sales by Application (2017-2022) & (K Units) Table 86. Latin America Gabapentin Enacarbil Sales by Application (2023-2028) & (K Units) Table 87. Latin America Gabapentin Enacarbil Revenue by Application (2017-2022) & (US$ Million) Table 88. Latin America Gabapentin Enacarbil Revenue by Application (2023-2028) & (US$ Million) Table 89. Latin America Gabapentin Enacarbil Sales by Country (2017-2022) & (K Units) Table 90. Latin America Gabapentin Enacarbil Sales by Country (2023-2028) & (K Units) Table 91. Latin America Gabapentin Enacarbil Revenue by Country (2017-2022) & (US$ Million) Table 92. Latin America Gabapentin Enacarbil Revenue by Country (2023-2028) & (US$ Million) Table 93. Middle East and Africa Gabapentin Enacarbil Sales by Type (2017-2022) & (K Units) Table 94. Middle East and Africa Gabapentin Enacarbil Sales by Type (2023-2028) & (K Units) Table 95. Middle East and Africa Gabapentin Enacarbil Revenue by Type (2017-2022) & (US$ Million) Table 96. Middle East and Africa Gabapentin Enacarbil Revenue by Type (2023-2028) & (US$ Million) Table 97. Middle East and Africa Gabapentin Enacarbil Sales by Application (2017-2022) & (K Units) Table 98. Middle East and Africa Gabapentin Enacarbil Sales by Application (2023-2028) & (K Units) Table 99. Middle East and Africa Gabapentin Enacarbil Revenue by Application (2017-2022) & (US$ Million) Table 100. Middle East and Africa Gabapentin Enacarbil Revenue by Application (2023-2028) & (US$ Million) Table 101. Middle East and Africa Gabapentin Enacarbil Sales by Country (2017-2022) & (K Units) Table 102. Middle East and Africa Gabapentin Enacarbil Sales by Country (2023-2028) & (K Units) Table 103. Middle East and Africa Gabapentin Enacarbil Revenue by Country (2017-2022) & (US$ Million) Table 104. Middle East and Africa Gabapentin Enacarbil Revenue by Country (2023-2028) & (US$ Million) Table 105. Arbor Pharma Corporation Information Table 106. Arbor Pharma Description and Major Businesses Table 107. Arbor Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 108. Arbor Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications Table 109. Arbor Pharma Recent Developments Table 110. Astellas Corporation Information Table 111. Astellas Description and Major Businesses Table 112. Astellas Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 113. Astellas Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications Table 114. Astellas Recent Developments Table 115. GlaxoSmithKline Corporation Information Table 116. GlaxoSmithKline Description and Major Businesses Table 117. GlaxoSmithKline Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 118. GlaxoSmithKline Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications Table 119. GlaxoSmithKline Recent Developments Table 120. Glenmark Pharma Corporation Information Table 121. Glenmark Pharma Description and Major Businesses Table 122. Glenmark Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 123. Glenmark Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications Table 124. Glenmark Pharma Recent Developments Table 125. Pfizer Corporation Information Table 126. Pfizer Description and Major Businesses Table 127. Pfizer Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 128. Pfizer Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications Table 129. Pfizer Recent Developments Table 130. Depomed Corporation Information Table 131. Depomed Description and Major Businesses Table 132. Depomed Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 133. Depomed Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications Table 134. Depomed Recent Developments Table 135. Teva Corporation Information Table 136. Teva Description and Major Businesses Table 137. Teva Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 138. Teva Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications Table 139. Teva Recent Developments Table 140. Mylan Corporation Information Table 141. Mylan Description and Major Businesses Table 142. Mylan Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 143. Mylan Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications Table 144. Mylan Recent Developments Table 145. Novartis Corporation Information Table 146. Novartis Description and Major Businesses Table 147. Novartis Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 148. Novartis Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications Table 149. Novartis Recent Developments Table 150. Apotex Corporation Information Table 151. Apotex Description and Major Businesses Table 152. Apotex Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 153. Apotex Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications Table 154. Apotex Recent Developments Table 155. Sun Pharmaceutical Corporation Information Table 156. Sun Pharmaceutical Description and Major Businesses Table 157. Sun Pharmaceutical Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 158. Sun Pharmaceutical Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications Table 159. Sun Pharmaceutical Recent Developments Table 160. Aurobindo Pharma Corporation Information Table 161. Aurobindo Pharma Description and Major Businesses Table 162. Aurobindo Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 163. Aurobindo Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications Table 164. Aurobindo Pharma Recent Developments Table 165. Intas Corporation Information Table 166. Intas Description and Major Businesses Table 167. Intas Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 168. Intas Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications Table 169. Intas Recent Developments Table 170. Amneal Corporation Information Table 171. Amneal Description and Major Businesses Table 172. Amneal Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 173. Amneal Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications Table 174. Amneal Recent Developments Table 175. Marksans Pharma Corporation Information Table 176. Marksans Pharma Description and Major Businesses Table 177. Marksans Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 178. Marksans Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications Table 179. Marksans Pharma Recent Developments Table 180. Alkem Corporation Information Table 181. Alkem Description and Major Businesses Table 182. Alkem Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 183. Alkem Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications Table 184. Alkem Recent Developments Table 185. Jiangsu Enhua Corporation Information Table 186. Jiangsu Enhua Description and Major Businesses Table 187. Jiangsu Enhua Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 188. Jiangsu Enhua Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications Table 189. Jiangsu Enhua Recent Developments Table 190. Jiangsu Hengrui Corporation Information Table 191. Jiangsu Hengrui Description and Major Businesses Table 192. Jiangsu Hengrui Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 193. Jiangsu Hengrui Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications Table 194. Jiangsu Hengrui Recent Developments Table 195. Sailike Pharma Corporation Information Table 196. Sailike Pharma Description and Major Businesses Table 197. Sailike Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 198. Sailike Pharma Gabapentin Enacarbil Product Model Numbers, Pictures, Descriptions and Specifications Table 199. Sailike Pharma Recent Developments Table 200. Key Raw Materials Lists Table 201. Raw Materials Key Suppliers Lists Table 202. Gabapentin Enacarbil Distributors List Table 203. Gabapentin Enacarbil Customers List Table 204. Gabapentin Enacarbil Market Trends Table 205. Gabapentin Enacarbil Market Drivers Table 206. Gabapentin Enacarbil Market Challenges Table 207. Gabapentin Enacarbil Market Restraints Table 208. Research Programs/Design for This Report Table 209. Key Data Information from Secondary Sources Table 210. Key Data Information from Primary Sources List of Figures Figure 1. Gabapentin Enacarbil Product Picture Figure 3. Global Gabapentin Enacarbil Market Share by Type in 2021 & 2028 Figure 3. Capsule Product Picture Figure 4. Tablet Product Picture Figure 5. Global Gabapentin Enacarbil Market Share by Application in 2021 & 2028 Figure 6. Post-Herpetic Neuralgia (PHN) Figure 7. Restless Legs Syndrome (RLS) Figure 8. Others Figure 9. Gabapentin Enacarbil Report Years Considered Figure 10. Global Gabapentin Enacarbil Sales 2017-2028 (K Units) Figure 11. Global Gabapentin Enacarbil Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Gabapentin Enacarbil Revenue 2017-2028 (US$ Million) Figure 13. Global Gabapentin Enacarbil Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 14. Global Gabapentin Enacarbil Sales Market Share by Region (2017-2022) Figure 15. Global Gabapentin Enacarbil Sales Market Share by Region (2023-2028) Figure 16. North America Gabapentin Enacarbil Sales YoY (2017-2028) & (K Units) Figure 17. North America Gabapentin Enacarbil Revenue YoY (2017-2028) & (US$ Million) Figure 18. Europe Gabapentin Enacarbil Sales YoY (2017-2028) & (K Units) Figure 19. Europe Gabapentin Enacarbil Revenue YoY (2017-2028) & (US$ Million) Figure 20. Asia-Pacific Gabapentin Enacarbil Sales YoY (2017-2028) & (K Units) Figure 21. Asia-Pacific Gabapentin Enacarbil Revenue YoY (2017-2028) & (US$ Million) Figure 22. Latin America Gabapentin Enacarbil Sales YoY (2017-2028) & (K Units) Figure 23. Latin America Gabapentin Enacarbil Revenue YoY (2017-2028) & (US$ Million) Figure 24. Middle East & Africa Gabapentin Enacarbil Sales YoY (2017-2028) & (K Units) Figure 25. Middle East & Africa Gabapentin Enacarbil Revenue YoY (2017-2028) & (US$ Million) Figure 26. The Gabapentin Enacarbil Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 27. The Top 5 and 10 Largest Manufacturers of Gabapentin Enacarbil in the World: Market Share by Gabapentin Enacarbil Revenue in 2021 Figure 28. Global Gabapentin Enacarbil Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 29. Global Gabapentin Enacarbil Sales Market Share by Type (2017-2028) Figure 30. Global Gabapentin Enacarbil Revenue Market Share by Type (2017-2028) Figure 31. Global Gabapentin Enacarbil Sales Market Share by Application (2017-2028) Figure 32. Global Gabapentin Enacarbil Revenue Market Share by Application (2017-2028) Figure 33. North America Gabapentin Enacarbil Sales Market Share by Type (2017-2028) Figure 34. North America Gabapentin Enacarbil Revenue Market Share by Type (2017-2028) Figure 35. North America Gabapentin Enacarbil Sales Market Share by Application (2017-2028) Figure 36. North America Gabapentin Enacarbil Revenue Market Share by Application (2017-2028) Figure 37. North America Gabapentin Enacarbil Sales Share by Country (2017-2028) Figure 38. North America Gabapentin Enacarbil Revenue Share by Country (2017-2028) Figure 39. United States Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million) Figure 40. Canada Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million) Figure 41. Europe Gabapentin Enacarbil Sales Market Share by Type (2017-2028) Figure 42. Europe Gabapentin Enacarbil Revenue Market Share by Type (2017-2028) Figure 43. Europe Gabapentin Enacarbil Sales Market Share by Application (2017-2028) Figure 44. Europe Gabapentin Enacarbil Revenue Market Share by Application (2017-2028) Figure 45. Europe Gabapentin Enacarbil Sales Share by Country (2017-2028) Figure 46. Europe Gabapentin Enacarbil Revenue Share by Country (2017-2028) Figure 47. Germany Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million) Figure 48. France Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million) Figure 49. U.K. Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million) Figure 50. Italy Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million) Figure 51. Russia Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million) Figure 52. Asia Pacific Gabapentin Enacarbil Sales Market Share by Type (2017-2028) Figure 53. Asia Pacific Gabapentin Enacarbil Revenue Market Share by Type (2017-2028) Figure 54. Asia Pacific Gabapentin Enacarbil Sales Market Share by Application (2017-2028) Figure 55. Asia Pacific Gabapentin Enacarbil Revenue Market Share by Application (2017-2028) Figure 56. Asia Pacific Gabapentin Enacarbil Sales Share by Region (2017-2028) Figure 57. Asia Pacific Gabapentin Enacarbil Revenue Share by Region (2017-2028) Figure 58. China Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million) Figure 59. Japan Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million) Figure 60. South Korea Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million) Figure 61. India Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million) Figure 62. Australia Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million) Figure 63. China Taiwan Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million) Figure 64. Indonesia Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million) Figure 65. Thailand Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million) Figure 66. Malaysia Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million) Figure 67. Latin America Gabapentin Enacarbil Sales Market Share by Type (2017-2028) Figure 68. Latin America Gabapentin Enacarbil Revenue Market Share by Type (2017-2028) Figure 69. Latin America Gabapentin Enacarbil Sales Market Share by Application (2017-2028) Figure 70. Latin America Gabapentin Enacarbil Revenue Market Share by Application (2017-2028) Figure 71. Latin America Gabapentin Enacarbil Sales Share by Country (2017-2028) Figure 72. Latin America Gabapentin Enacarbil Revenue Share by Country (2017-2028) Figure 73. Mexico Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million) Figure 74. Brazil Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million) Figure 75. Argentina Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million) Figure 76. Middle East and Africa Gabapentin Enacarbil Sales Market Share by Type (2017-2028) Figure 77. Middle East and Africa Gabapentin Enacarbil Revenue Market Share by Type (2017-2028) Figure 78. Middle East and Africa Gabapentin Enacarbil Sales Market Share by Application (2017-2028) Figure 79. Middle East and Africa Gabapentin Enacarbil Revenue Market Share by Application (2017-2028) Figure 80. Middle East and Africa Gabapentin Enacarbil Sales Share by Country (2017-2028) Figure 81. Middle East and Africa Gabapentin Enacarbil Revenue Share by Country (2017-2028) Figure 82. Turkey Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million) Figure 83. Saudi Arabia Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million) Figure 84. UAE Gabapentin Enacarbil Revenue (2017-2028) & (US$ Million) Figure 85. Gabapentin Enacarbil Value Chain Figure 86. Gabapentin Enacarbil Production Process Figure 87. Channels of Distribution Figure 88. Distributors Profiles Figure 89. Bottom-up and Top-down Approaches for This Report Figure 90. Data Triangulation Figure 91. Key Executives Interviewed

Purchase Report

Single User 3480
Multi User 5250
Corporate User 6960
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.